These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 21798602
1. Inflammation in psychotic disorders: a population-based study. Suvisaari J, Loo BM, Saarni SE, Haukka J, Perälä J, Saarni SI, Viertiö S, Partti K, Lönnqvist J, Jula A. Psychiatry Res; 2011 Sep 30; 189(2):305-11. PubMed ID: 21798602 [Abstract] [Full Text] [Related]
2. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. Hope S, Dieset I, Agartz I, Steen NE, Ueland T, Melle I, Aukrust P, Andreassen OA. J Psychiatr Res; 2011 Dec 30; 45(12):1608-16. PubMed ID: 21889167 [Abstract] [Full Text] [Related]
4. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Raison CL, Lin JM, Reeves WC. Brain Behav Immun; 2009 Mar 30; 23(3):327-37. PubMed ID: 19111923 [Abstract] [Full Text] [Related]
5. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission. Tsai SY, Chung KH, Huang SH, Chen PH, Lee HC, Kuo CJ. Bipolar Disord; 2014 Dec 30; 16(8):800-8. PubMed ID: 25130211 [Abstract] [Full Text] [Related]
7. Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue. Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fosså SD. Brain Behav Immun; 2009 Aug 30; 23(6):868-74. PubMed ID: 19362138 [Abstract] [Full Text] [Related]
8. Inflammatory evidence for the psychosis continuum model. Mørch RH, Dieset I, Færden A, Hope S, Aas M, Nerhus M, Gardsjord ES, Joa I, Morken G, Agartz I, Aukrust P, Djurovic S, Melle I, Ueland T, Andreassen OA. Psychoneuroendocrinology; 2016 May 30; 67():189-97. PubMed ID: 26923849 [Abstract] [Full Text] [Related]
15. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Am J Med; 2006 Jun 30; 119(6):526.e9-17. PubMed ID: 16750969 [Abstract] [Full Text] [Related]
16. Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study. Mørch RH, Dieset I, Faerden A, Hope S, Aas M, Nerhus M, Gardsjord ES, Haram M, Falk RS, Joa I, Morken G, Agartz I, Aukrust P, Djurovic S, Melle I, Ueland T, Andreassen OA. Acta Psychiatr Scand; 2017 Oct 30; 136(4):400-408. PubMed ID: 28815548 [Abstract] [Full Text] [Related]
19. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors. Paik JK, Kim OY, Koh SJ, Jang Y, Chae JS, Kim JY, Kim HJ, Hyun YJ, Cho JR, Lee JH. Clin Chim Acta; 2007 May 01; 380(1-2):68-74. PubMed ID: 17335789 [Abstract] [Full Text] [Related]
20. Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms. Stojanovic A, Martorell L, Montalvo I, Ortega L, Monseny R, Vilella E, Labad J. Psychoneuroendocrinology; 2014 Mar 01; 41():23-32. PubMed ID: 24495605 [Abstract] [Full Text] [Related] Page: [Next] [New Search]